Isolation and structure of turbostatins 1-4
View Patent ↗Described herein are novel cerebroside compounds, designated as Turbostatin 1, Turbostatin 2, Turbostatin 3, and Turbostatin 4. These compounds were extracted and isolated from the marine mollusk Turbo stenogyrus , and their structures elucidated. The new compounds exhibit significant cancer cell growth inhibition activity against a variety of murine and human cancer cell lines, and as such appear will be useful in the treatment of various forms of neoplastic disease.
1. An isolated compound having the following structure:
wherein n=13, and salts thereof.
2. An isolated compound having the following structure:
wherein n=15, and salts thereof.
3. An isolated compound having the following structure:
wherein n=13, and salts thereof.
4. An isolated compound having the following structure:
wherein n=15, and salts thereof.
5. A composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
6. A composition comprising the compound of claim 2 and a pharmaceutically acceptable carrier.
7. A composition comprising the compound of claim 3 and a pharmaceutically acceptable carrier.
8. A composition comprising the compound of claim 4 and a pharmaceutically acceptable carrier.
9. A method for treating a neoplastic disease in a patient, comprising administering to the said patient an effective amount of the composition of claim 5 .
10. A method for treating a neoplastic disease in a patient, comprising administering to the said patient an effective amount of the composition of claim 6 .
11. A method for treating a neoplastic disease in a patient, comprising administering to the said patient an effective amount of the composition of claim 7 .
12. A method for treating a neoplastic disease in a patient, comprising administering to the said patient an effective amount of the composition of claim 8 .
13. A method for the isolation of a compound selected from the group consisting of
wherein n=13 or 15
or
wherein n=13 or 15
comprising the steps of:
a. forming a 2-propanol extract of Turbo stenogyrus;
b. subjecting the 2-proponal extract to a 9:1→3:2 CH 3 OH—H 2 O/Hexane→CH 2 Cl 2 solvent partition sequence to product a methylene chloride extract;
c. fractionating the methylene chloride extract via a series of separations involving column gel permeation (Sephadex LH-20), partition chromatography;
d. subjecting the fractionated extract by reverse-phase HPLC columns on Zorbax SB-C18 in 85:15 CH 3 OH—H 2 O;
to obtain the compounds.